Through upregulating oxidative stress, ceramides inherently induce endothelial dysfunction through ROS-mediated uncoupling of eNOS leading to reduced nitric oxide (NO) bioavailability, increased ROS production and resultant vasoconstriction, and increased vascular permeability [57]. The gene discussed is NOS3; the disease is endothelial dysfunction.